ReviewJournal of cardiovascular and thoracic research2022

A glance at the application of CRISPR/Cas9 gene-editing technology in cardiovascular diseases.

Neda Roshanravan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.